176 related articles for article (PubMed ID: 17072810)
21. Impact of sex steroids on neuroinflammatory processes and experimental multiple sclerosis.
Kipp M; Beyer C
Front Neuroendocrinol; 2009 Jul; 30(2):188-200. PubMed ID: 19393685
[TBL] [Abstract][Full Text] [Related]
22. Microglia activation states and cannabinoid system: Therapeutic implications.
Mecha M; Carrillo-Salinas FJ; Feliú A; Mestre L; Guaza C
Pharmacol Ther; 2016 Oct; 166():40-55. PubMed ID: 27373505
[TBL] [Abstract][Full Text] [Related]
23. The role of cannabinoid system on immune modulation: therapeutic implications on CNS inflammation.
Correa F; Mestre L; Molina-Holgado E; Arévalo-Martín A; Docagne F; Romero E; Molina-Holgado F; Borrell J; Guaza C
Mini Rev Med Chem; 2005 Jul; 5(7):671-5. PubMed ID: 16026313
[TBL] [Abstract][Full Text] [Related]
24. Cannabinoid influence on cytokine profile in multiple sclerosis.
Katona S; Kaminski E; Sanders H; Zajicek J
Clin Exp Immunol; 2005 Jun; 140(3):580-5. PubMed ID: 15932522
[TBL] [Abstract][Full Text] [Related]
25. Neurobiology and systems physiology of the endocannabinoid system.
Wegener N; Koch M
Pharmacopsychiatry; 2009 May; 42 Suppl 1():S79-86. PubMed ID: 19434559
[TBL] [Abstract][Full Text] [Related]
26. Excitotoxicity in a chronic model of multiple sclerosis: Neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation.
Docagne F; Muñetón V; Clemente D; Ali C; Loría F; Correa F; Hernangómez M; Mestre L; Vivien D; Guaza C
Mol Cell Neurosci; 2007 Apr; 34(4):551-61. PubMed ID: 17229577
[TBL] [Abstract][Full Text] [Related]
27. Cannabinoid receptors as therapeutic targets in the management of liver diseases.
Mallat A; Lotersztajn S
Drug News Perspect; 2008 Sep; 21(7):363-8. PubMed ID: 19259549
[TBL] [Abstract][Full Text] [Related]
28. Cannabinoids and gastrointestinal motility: animal and human studies.
Aviello G; Romano B; Izzo AA
Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():81-93. PubMed ID: 18924447
[TBL] [Abstract][Full Text] [Related]
29. Multifaceted aspects of inflammation in multiple sclerosis: the role of microglia.
Muzio L; Martino G; Furlan R
J Neuroimmunol; 2007 Nov; 191(1-2):39-44. PubMed ID: 17936915
[TBL] [Abstract][Full Text] [Related]
30. Basic neuroanatomy and neuropharmacology of cannabinoids.
Breivogel CS; Sim-Selley LJ
Int Rev Psychiatry; 2009 Apr; 21(2):113-21. PubMed ID: 19367505
[TBL] [Abstract][Full Text] [Related]
31. Immune control by endocannabinoids - new mechanisms of neuroprotection?
Ullrich O; Merker K; Timm J; Tauber S
J Neuroimmunol; 2007 Mar; 184(1-2):127-35. PubMed ID: 17196262
[TBL] [Abstract][Full Text] [Related]
32. Potential roles of (endo)cannabinoids in the treatment of glaucoma: from intraocular pressure control to neuroprotection.
Nucci C; Bari M; Spanò A; Corasaniti M; Bagetta G; Maccarrone M; Morrone LA
Prog Brain Res; 2008; 173():451-64. PubMed ID: 18929127
[TBL] [Abstract][Full Text] [Related]
33. Modulation of inflammation in brain: a matter of fat.
Farooqui AA; Horrocks LA; Farooqui T
J Neurochem; 2007 May; 101(3):577-99. PubMed ID: 17257165
[TBL] [Abstract][Full Text] [Related]
34. Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures--a short review.
Svízenská I; Dubový P; Sulcová A
Pharmacol Biochem Behav; 2008 Oct; 90(4):501-11. PubMed ID: 18584858
[TBL] [Abstract][Full Text] [Related]
35. Endogenous signals initiating inflammation in the injured nervous system.
Pineau I; Lacroix S
Glia; 2009 Mar; 57(4):351-61. PubMed ID: 18803306
[TBL] [Abstract][Full Text] [Related]
36. The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview.
McCarberg BH; Barkin RL
Am J Ther; 2007; 14(5):475-83. PubMed ID: 17890938
[TBL] [Abstract][Full Text] [Related]
37. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.
Gaetani S; Dipasquale P; Romano A; Righetti L; Cassano T; Piomelli D; Cuomo V
Int Rev Neurobiol; 2009; 85():57-72. PubMed ID: 19607961
[TBL] [Abstract][Full Text] [Related]
38. Towards cannabis and cannabinoid treatment of multiple sclerosis.
Croxford JL; Miller SD
Drugs Today (Barc); 2004 Aug; 40(8):663-76. PubMed ID: 15510238
[TBL] [Abstract][Full Text] [Related]
39. Cannabinoid signalling in the enteric nervous system.
Galligan JJ
Neurogastroenterol Motil; 2009 Sep; 21(9):899-902. PubMed ID: 19689654
[TBL] [Abstract][Full Text] [Related]
40. Adult neural stem cells for the treatment of neuroinflammation. Fondazione Centro San Raffaele del Monte Tabor: WO2007015173.
Taupin P
Expert Opin Ther Pat; 2009 Mar; 19(3):373-6. PubMed ID: 19441909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
